- Home
- PMAX vs AIDX Comparison
PMAX vs AIDX Comparison
Compare PMAX & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | AIDX |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 2.9M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PMAX | AIDX |
|---|---|---|
| Price | $0.75 | $0.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 863.7K | 208.0K |
| Earning Date | 11-24-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | N/A | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.20 | $0.18 |
| 52 Week High | $4.81 | $18.96 |
Technical Indicators
Market Signals| Indicator | PMAX | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 28.39 |
| Support Level | $0.24 | N/A |
| Resistance Level | $1.09 | $0.27 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 46.27 | 16.65 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd operates as a financial communications platform supporting listed companies and IPO applicants throughout the capital markets lifecycle. Substantially all of the company's revenue is generated from Hong Kong. The group focused on supporting the disclosure, reporting, and transaction needs of corporate clients and their advisors. Its mission is to combine industry knowledge, execution capabilities, and a commitment to service to deliver accurate, timely, and reliable solutions for customers.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.